Health officials in India say they have treated more than 1,500 people suffering from depression with a new antidepressant medication after a spike in drug overdose deaths in recent months.
Indian health officials said Sunday that they had treated more people suffering with depression with the drug Abilify, which has been approved by the World Health Organization (WHO).
The drug was approved in December and has been in use in India since the middle of 2017, but the number of people who have died from the drug overdose has soared since then.
The drugs, which are sold by generics, are often used to treat depression.
A report from the Indian Medical Association said that since January, nearly 2,000 people have died after taking the drug.
In India, there are more than 10,000 drug-related deaths each year.
The report noted that Abilified has not been widely used in India, and that its use in emergency rooms has skyrocketed in recent years.